Get the Stockscreener App
32.39
3.31%
-1.11
After Hours:
32.39
Anbio Biotechnology stock is traded at $32.39, with a volume of 27,802.
It is down -3.31% in the last 24 hours and up +38.24% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$33.50
Open:
$33.49
24h Volume:
27,802
Relative Volume:
0.60
Market Cap:
$1.42B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.34%
1M Performance:
+38.24%
6M Performance:
+3.78%
1Y Performance:
+0.00%
1-Day Range:
$31.72
$34.00
1-Week Range:
$31.18
$38.00
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
32.39 | 1.47B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Anbio Biotechnology Stock (NNNN) Latest News
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛
Anbio Biotechnology rises 11.2% - MSN
Why Anbio Biotechnology Class A Shares Are Rising - TipRanks
Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Appoints New Auditor - TipRanks
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Why Anbio Biotechnology Stock is Tumbling - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Anbio Biotechnology (NNNN) Stock Price Today | Live Chart & News - Traders Union
Anbio Biotechnology (NNNN) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
Anbio Biotechnology falls -5.5% - MSN
Anbio Biotechnology falls -26.6% - MSN
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology Class A Ordinary Shares 7-Year Stock Forecast ( 2031 2032 - Meyka
Anbio Biotechnology (N3B.F) Stock Price, News, Quote & History - Yahoo
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology (N3B.F) Latest Press Releases & Corporate News - Yahoo
Page 795 - Laotian Times
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology rises 40.5% - MSN
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise In Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - 富途牛牛
S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's
Anbio Biotechnology Stock Tumbles Amid Volatility - TipRanks
Liverpool Ferry Port Faces Repairs Due to Berth Damage - Berawang News
Jake LaRavia Talks Lakers Role After JJ Redick’s Media Day Insights - Berawang News
Manchester United legend wants Arsenal to win the league – Daily Cannon - Berawang News
Will RSVR stock go up soonJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What does recent volatility data suggest for GAN Limited2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Ottobock plans 2025 IPO on Frankfurt exchange - BioWorld MedTech
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.33%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):